According to the public relations department of Actover Pharmaceutical Group, at this congress, organized by the Iranian Association of Gastroenterology and Hepatology (IAGH), which took place from December 4 to 7 at the Razi Conference Hall in Tehran, Actover Pharmaceutical Group made a prominent presence by presenting its latest pharmaceutical products.

Introduction of Actover’s Latest Products in the Field of Gastrointestinal and Liver Disease Treatment
Actover Pharmaceutical Group, with more than half a century of experience, utilizes the latest pharmaceutical production technologies in the world to offer over 300 products across 15 therapeutic fields. Among these, medications for the treatment of gastrointestinal and liver diseases form a significant portion of Actover’s product range:

Irojet (Ferric Carboxymaltose)

“Irojet” is the commercial name for “Ferric Carboxymaltose” produced at the Actoverco pharmaceutical plant. It is used as an iron substitute to treat iron deficiency anemia.
This iron supplement, available in an injectable vial form (500 mg in 10 mL, 50 mg per mL), is prescribed for the treatment of iron deficiency anemia.

Xigut (Rifaximin)

“Xigut” is the commercial name for “Rifaximin” produced by Actoverco pharmaceutical factory.
Xigut is a semi-synthetic antibiotic based on Rifamycin, available in film-coated tablets of 200 mg and 550 mg.
It is used to treat diarrhea, prevent brain-related complications from liver diseases, and treat irritable bowel syndrome (IBS).

Mesalover (Mesalazine)

“Mesalover” is the commercial name for “Mesalazine” or “Mesalarin,” produced by Actoverco Pharmaceutical Factory.
Mesalover (Mesalazine) belongs to a group of compounds known as 5-aminosalicylic acid and is available in extended-release capsule form (500 mg) and extended-release granules in 1, 2, and 4-gram doses.
This drug is used for the treatment and prevention of recurrent ulcerative colitis.
It is specifically used to treat mild to moderate ulcerative colitis in the large intestine.

Motilover (Domperidone)

“Domperidone” is a gastrointestinal drug produced under the commercial name “Motilover” by Actoverco Pharmaceutical Factory.
This drug, available in 10 mg coated tablets, is used to treat delayed gastric motility, prevent stomach discomfort, and reduce nausea and vomiting induced by medications used in Parkinson’s disease.

Nolpaza (Pantoprazole)

Nolpaza is the commercial name for Pantoprazole, produced by Actoverco Pharmaceutical Factory under the license of KRKA, Slovenia.
Pantoprazole, a proton pump inhibitor, is available in enteric-coated tablets of 20 mg and 40 mg.
This drug is used to treat gastroesophageal reflux disease (GERD) and conditions related to increased gastric acid secretion.

Mebacto (Mebeverine)

Mebacto is the commercial name for Mebeverine, produced by Actoverco Pharmaceutical Factory. It belongs to a group of drugs known as antispasmodics.
This drug is available in 135 mg coated tablets and 200 mg extended-release capsules. It helps relax the muscles of the gastrointestinal system (intestines).
Mebacto is used to treat conditions such as irritable bowel syndrome (IBS), constipation, spastic colitis, and mucosal colitis.

Ursyl® (Ursodeoxycholic Acid)

Ursyl® is the commercial name for Ursodeoxycholic Acid, produced by Actoverco Pharmaceutical Company in 300 mg capsule form. Ursodeoxycholic acid is a bile acid that is naturally and in small amounts found in human bile. This compound plays a role in reducing bile cholesterol levels and gallstones.
This drug is used not only for the treatment or prevention of gallstones but also for treating children aged 6 to 18 years with liver and biliary disorders caused by cystic fibrosis, as well as for treating primary biliary cirrhosis, a liver disease caused by bile duct problems.